Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Reed’s Syndrome

  • Chapter
  • First Online:
Acneiform Eruptions in Dermatology

  • 1711 Accesses

Abstract

Multiple cutaneous and uterine leiomyomatosis (MCUL), also known as Reed’s syndrome, is an autosomal dominant genetic condition. Affected individuals have an increased predisposition to develop benign smooth muscle tumors (leiomyomas) in the skin and uterus. Affected females frequently develop uterine leiomyomas (fibroids) that are larger and more numerous and emerge earlier than those in the general population. Subsets of these patients are at risk for renal cell carcinoma (RCC) and have been determined to have mutations in the fumarate hydratase (FH) gene. In individuals or families without RCC, the syndrome may be referred to as multiple cutaneous leiomyomatosis (MCL) or MCUL. The term hereditary leiomyomatosis and RCC (HLRCC) refers to families with an increased prevalence of smooth muscle tumors and RCC as a result of the FH genetic defect. Since cutaneous leiomyomas are not exceptionally common, their presence—whether single or in multiplicity—should raise suspicion of underlying uterine leiomyomas and the possibility of real disease. Increased clinical awareness is important due to the association between coexisting cutaneous and systemic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hereditary leiomyomatosis and renal cell cancer. Available at http://ghr.nlm.nih.gov/condition=hereditaryleiomyomatosisandrenalcellcancer. Accessed 18 Sep 2012

    Google Scholar 

  2. Reed WB, Walker R, Horowitz R. Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol. 1973;53(5):409–16.

    PubMed  CAS  Google Scholar 

  3. Kloepfer HW, Krafchuk J, Derbes V, Burks J. Hereditary multiple leiomyoma of the skin. Am J Hum Genet. 1958;10(1):48–52.

    PubMed  CAS  Google Scholar 

  4. Holst VA, Junkins-Hopkins JM, Elenitsas R. Cutaneous smooth muscle neoplasms: clinical features, histologic findings, and treatment options. J Am Acad Dermatol. 2002;46(4): 477–90.

    Article  PubMed  Google Scholar 

  5. Costella TM, Romiti N, Almeida JR, et al. Do you know this syndrome? An Bras Dermatol. 2011;86(4):815–24.

    Article  PubMed  Google Scholar 

  6. Orellana Diaz O, Hernandez PE. Leiomyoma cutis and leiomyosarcoma: a 10-year study and a short review. J Dermatol Surg Oncol. 1983;9(4):283–7.

    Article  PubMed  CAS  Google Scholar 

  7. Badeloe S, Frank J. Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis. Eur J Dermatol. 2009;19(6):545–51.

    PubMed  CAS  Google Scholar 

  8. Malhotra P, Walia H, Singh A, Ramesh V. Leiomyoma cutis: a clinicopathological series of 37 cases. Indian J Dermatol. 2010;55(4):337–41.

    Article  PubMed  Google Scholar 

  9. Wei MH, Toure O, Glenn GM, et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. 2006;43(1):18–27.

    Article  PubMed  CAS  Google Scholar 

  10. Kiuru M, Launonen V. Hereditary leiomyomatosis and renal cell cancer (HLRCC). Curr Mol Med. 2004;4(8):869–75.

    Article  PubMed  CAS  Google Scholar 

  11. García Muret MP, Pujol RM, Alomar A, et al. Familial leiomyomatosis cutis et uteri (Reed’s syndrome). Arch Dermatol Res. 1988;280:S29–32.

    Article  PubMed  Google Scholar 

  12. Toro JR, Nickerson ML, Wei MH, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003;73(1):95–106.

    Article  PubMed  CAS  Google Scholar 

  13. Alam NA, Olpin S, Leigh IM. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol. 2005;153(1):11–7.

    Article  PubMed  CAS  Google Scholar 

  14. Tomlinson IP, Alam NA, Rowan AJ, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002;30(4):406–10.

    Article  PubMed  CAS  Google Scholar 

  15. Kiuru M, Launonen V, Hietala M, et al. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol. 2001; 159(3):825–9.

    Article  PubMed  CAS  Google Scholar 

  16. Alam NA, Bevan S, Churchman M, et al. Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3–q43. Am J Hum Genet. 2001;68(5):1264–9.

    Article  PubMed  CAS  Google Scholar 

  17. Alam NA, Rowan AJ, Wortham NC, et al. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet. 2003;12(11):1241–52.

    Article  PubMed  CAS  Google Scholar 

  18. Badeloe S, van Geel M, van Steensel MA, et al. Diffuse and segmental variants of cutaneous leiomyomatosis: novel mutations in the fumarate hydratase gene and review of the literature. Exp Dermatol. 2006;15(9):735–41.

    Article  PubMed  CAS  Google Scholar 

  19. Sudarshan S, Pinto PA, Neckers L, Linehan WM. Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer—a distinct form of hereditary kidney cancer. Nat Clin Pract Urol. 2007;4(2):104–10.

    Article  PubMed  CAS  Google Scholar 

  20. Mitchum MD, Adams EG, Holcomb KZ. JAAD Grand Rounds quiz. A 46-year-old man with agminated papules on the buttock. Reed syndrome. J Am Acad Dermatol. 2012;66(2):337–9.

    Article  PubMed  Google Scholar 

  21. Smith CG, Glaser DA, Leonardi C. Zosteriform multiple leiomyomas. J Am Acad Dermatol. 1998;38(2 Pt 1):272–3.

    Article  PubMed  CAS  Google Scholar 

  22. Naverson DN, Trask DM, Watson FH, Burket JM. Painful tumors of the skin: “LEND AN EGG”. J Am Acad Dermatol. 1993;28(2 Pt 2):298–300.

    Article  Google Scholar 

  23. Apatenko AK, Turusov VS. The painful tumours of the skin. Neoplasma. 1968;15(2): 187–202.

    PubMed  CAS  Google Scholar 

  24. Lehtonen HJ. Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer. 2011;10(2):397–411.

    Article  PubMed  Google Scholar 

  25. Kilpatrick SE, Mentzel T, Fletcher CD. Leiomyoma of deep soft tissue. Clinicopathologic analysis of a series. Am J Surg Pathol. 1994;18(6):576–82.

    Article  PubMed  CAS  Google Scholar 

  26. Spencer JM, Amonette RA. Tumors with smooth muscle differentiation. Dermatol Surg. 1996;22(9):761–8.

    Article  PubMed  CAS  Google Scholar 

  27. Miettinen M, Lehto VP, Virtanen I. Antibodies to intermediate filament proteins. The differential diagnosis of cutaneous tumors. Arch Dermatol. 1985;121(6):736–41.

    Article  PubMed  CAS  Google Scholar 

  28. McGinley KM, Bryant S, Kattine AA, et al. Cutaneous leiomyomas lack estrogen and progesterone receptor immunoreactivity. J Cutan Pathol. 1997;24(4):241–5.

    Article  PubMed  CAS  Google Scholar 

  29. Pithukpakorn M, Toro JR. Hereditary leiomyomatosis and renal cell cancer. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. Genereviews. Seattle, Washington: University of Washington; 1993–2006.

    Google Scholar 

  30. Rongioletti F, Fausti V, Ferrando B, et al. A novel missense mutation in fumarate hydratase in an Italian patient with a diffuse variant of cutaneous leiomyomatosis (Reed’s syndrome). Dermatology. 2010;221(4):378–80.

    Article  PubMed  CAS  Google Scholar 

  31. Fisher WC, Helwig EB. Leiomyomas of the skin. Arch Dermatol. 1963;88:510–20.

    Article  PubMed  CAS  Google Scholar 

  32. Montgomery H, Winkelmann RK. Smooth-muscle tumors of the skin. AMA Arch Derm. 1959;79(1):32–40.

    Article  PubMed  CAS  Google Scholar 

  33. George S, Pulimood S, Jacob M, Chandi SM. Pain in multiple leiomyomas alleviated by nifedipine. Pain. 1997;73(1):101–2.

    Article  PubMed  CAS  Google Scholar 

  34. Thompson JA. Jr Therapy for painful cutaneous leiomyomas. J Am Acad Dermatol. 1985;13(5 Pt 2):865–7.

    Article  PubMed  Google Scholar 

  35. Batchelor RJ, Lyon CC, Highet AS. Successful treatment of pain in two patients with cutaneous leiomyomata with the oral alpha-1 adrenoceptor antagonist, doxazosin. Br J Dermatol. 2004;150(4):775–6.

    Article  PubMed  CAS  Google Scholar 

  36. Thyresson HN, Su WP. Familial cutaneous leiomyomatosis. J Am Acad Dermatol. 1981; 4(4):430–4.

    Article  PubMed  CAS  Google Scholar 

  37. Haugen RN, Tharp MD. The use of gabapentin for recurrent painful attacks with multiple piloleiomyomas. J Drugs Dermatol. 2008;7(4):401–2.

    PubMed  Google Scholar 

  38. Sifaki MK, Krueger-Krasagakis S, Koutsopoulos A, et al. Botulinum toxin type A-treatment of a patient with multiple cutaneous piloleiomyomas. Dermatology. 2009;218(1):44–7.

    Article  PubMed  CAS  Google Scholar 

  39. Onder M, Adien E. A new indication of botulinum toxin: leiomyoma-related pain. J Am Acad Dermatol. 2009;60(2):325–8.

    Article  PubMed  Google Scholar 

  40. Christenson LJ, Smith K, Arpey CJ. Treatment of multiple cutaneous leiomyomas with CO2 laser ablation. Dermatol Surg. 2000;26(4):319–22.

    Article  PubMed  CAS  Google Scholar 

  41. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26(5):785–93.

    Article  PubMed  CAS  Google Scholar 

  42. Aoki KR. Pharmacology and immunology of botulinum toxin type A. Clin Dermatol. 2003; 21(6):476–80.

    Article  PubMed  Google Scholar 

  43. Hindley JT, Law PA, Hickey M, et al. Clinical outcomes following percutaneous magnetic resonance image guided laser ablation of symptomatic uterine fibroids. Hum Reprod. 2002; 17(10):2737–41.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Mount Sinai School of Medicine, New York, NY, USA

    Kristen Pacific B.A. & Jason Emer M.D.

Authors
  1. Kristen Pacific B.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jason Emer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jason Emer M.D. .

Editor information

Editors and Affiliations

  1. Mount Sinai Medical Center, New York, USA

    Joshua Zeichner

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Pacific, K., Emer, J. (2014). Reed’s Syndrome. In: Zeichner, J. (eds) Acneiform Eruptions in Dermatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8344-1_32

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8344-1_32

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8343-4

  • Online ISBN: 978-1-4614-8344-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation